Collectively, our data demonstrate that entinostat elicits a PI-3K/Akt/mTOR pathway-independent mechanism to downregulate Survivin, which is essential for entinostat to potentiate paclitaxel-mediated cytotoxicity in NSCLC cells. The gene discussed is BIRC5; the disease is non-small cell lung carcinoma.